Trial Profile

The Effect of Dienogest vs. Norethindrone Acetate Treatment in Endometriosis

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 06 Jun 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dienogest (Primary) ; Norethisterone
Indications Endometriosis
Focus Therapeutic Use
Acronyms DINE

Most Recent Events

01 Jun 2025 Results(n=70) suggesting NETA 5 mg/day may be a better approach instead of dienogest for the endometriosis treatment were published in the European Journal of Obstetrics and Gynecology and Reproductive Biology
20 Jul 2023 Status has been changed to completed.
25 Feb 2023 Planned primary completion date changed from 30 Nov 2022 to 30 Mar 2023.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com